Name: Capital Market Publishers India Pvt. Ltd.
Telephone: 91-22-25229720

LOGIN HERE

Cancel

BSE Code : 531380 | NSE Symbol : | ISIN : INE405H01018 | Industry : Healthcare |

Board Meeting

Announcement Date	Date Of Meeting	Purpose	Detail
08-Feb-2025	14-Feb-2025	Quarterly Results	CENTENIAL SURGICAL SUTURE LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2025 inter alia to consider and approve 1. To approve the Standalone Un-Audited Financial Results for the quarter and nine months ended December 31 2024. 2. Any other business with the permission of chair. With reference to the above captioned subject, we wish to inform you that the Board of Directors of the Company at their meeting held on Friday, February 14, 2025 at 03.00 p.m. approved the following: Standalone Un-Audited Financial Results for the quarter and nine months ended December 31, 2024 as per Regulation 33 of SEBI (LODR) Regulations, 2015. The meeting was concluded at 03.30 p.m. (As Per BSE Announcement Dated on 14.02.2025)
07-Nov-2024	14-Nov-2024	Quarterly Results	CENTENIAL SURGICAL SUTURE LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2024 inter alia to consider and approve 1. To approve Standalone Un-Audited Financial Results for the quarter and half year ended on September 30 2024 pursuant to Regulation 33 of SEBI (LODR) Regulation 2015. 2. To approve the Statement of Assets and Liabilities for the half year ended September 30 2024. 3. Cash Flow Statement for the half year ended September 30 2024. 4. Any other business with the permission of chair. 1). Standalone Un-Audited Financial Results for the quarter and half year ended September 30, 2024 as per Regulation 33 of SEBI (LODR) Regulations, 2015. 2). Statement of Assets and Liabilities for the half year ended September 30, 2024. 3). Cash Flow Statement for the half year ended September 30, 2024. 4). Related party transaction for the half year ended September 30, 2024. (As Per BSE Announcement dated on 14.11.2024)
03-Aug-2024	12-Aug-2024	Quarterly Results	CENTENIAL SURGICAL SUTURE LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2024 inter alia to consider and approve 1. To approve Standalone Un-Audited Financial Results for the quarter ended on June 30 2024 pursuant to Regulation 33 of SEBI (LODR) Regulation 2015. 2. To consider and approve appointment of M/s. HSPN & Associates LLP. Company Secretaries as Secretarial Auditors of the Company for the Financial Year 2024-2025. 3. To consider and approve appointment of M/s. Utsav Shah & Associates Chartered Accountants as Internal Auditors of the Company for the Financial Year 2024-2025. 4. To consider and approve re-appointment of Shri Vijay Majrekar (DIN: 00804808) as a Managing Director of the Company for further period of 05 (Five) years. 5. To approve the Book-closure dates as per Regulation 42 of the SEBI (LODR) Regulations 2015 for the purpose of 29th Annual General Meeting of the Company. 6. To fix the Date Time and Venue for convening 29th Annual General Meeting of the Members of the Company and approve the Draft Notice for the same. 7. Any other business with the permission of chair. 1). Approval of Standalone UFR for the quarter ended June 30, 2024 as per Reg 33 of SEBI (LODR) Reg, 2015. 2). Limited Review Report for the quarter ended June 30, 2024. 3). Notice of 29th e-AGM FY 2023-24. 4). Dates of closure of the Share Transfer Books & Register of Members as per Reg 42 (2) of the SEBI (LODR) for the purpose of 29th e-AGM to be held on Friday the Sept 27, 2024. 5). Venue, Day, Date & time of the 29th e-AGM. 6). Fixation of Cut-off date to record the entitlement of the Shareholders to cast their votes at the 29th AGM. 7). Appointment of HSPN & Associates LLP, CS as the Secretarial Auditor for the FY 2024-25 to conduct the Secretarial Audit. 8). Appointment of M/s. Utsav Shah & Associates, CA, Internal Auditor for the FY 2024-2025 to conduct the Internal Audit. Further, the Board defers to the proposal of Re-appointment of Vijay Majrekar (DIN: 00804808) as a MD. The said meeting commenced at 02:35 p.m. & concluded at 03:30 p.m. (As Per BSE Announcement Dated on: 12/08/2024)
20-May-2024	28-May-2024	Accounts	CENTENIAL SURGICAL SUTURE LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/05/2024 inter alia to consider and approve 1) To approve Standalone Audited Financial Results along with Auditors Report for the quarter and year ended on March 31 2024 pursuant to Regulation 33 of SEBI (LODR) Regulations 2015. 2) Any other business with the permission of chair. With reference to the above captioned subject, we wish to inform you that the Board of Directors of the Company at their meeting held on Tuesday, the May 28, 2024 approved the following: 1). Approval of Standalone Audited Financial Results for the quarter and year ended March 31, 2024 as per Regulation 33 of SEBI (LODR) Regulations, 2015. 2). Also, note that Statutory Auditors of the Company have issued the Auditor's Report for the financial year ended March 31, 2024 with unmodified opinion pursuant to Regulation 33(3)(d) of the SEBI(LODR), Regulations, 2015. 3). Disclosure of Related Party Transaction pursuant to Regulation 23(9) of the SEBI(LODR), Regulations, 2015. The said meeting commenced at 03:35 p.m. and concluded at 04:35 p.m. Read less.. (As Per BSE Announcement Dated on 28.05.2024)
25-Apr-2024	29-Apr-2024	Postal Ballot	CENTENIAL SURGICAL SUTURE LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/04/2024 inter alia to consider and approve 1). To consider and approve the postal ballot notice. 2). To appoint scrutinizer for the postal ballot. 3). Regularisation of additional Independent Non-Executive Directors of the Company. 4). Increasing borrowing power pursuant to section 180(1)(c) of the Companies Act 2023. 5). Any other business with permission of chair. Meeting held on Monday, the April 29, 2024 at 07.15 p.m. in which the Board has approved the following: 1. Approval of Notice of Postal Ballot seeking consent of the Members through electronic voting (remote e-voting) in relation to following special resolution: (a) Appointment of Ms. Ridhima Limaye (DIN: 10256393) as an INED of the Company for a period of 05 years w.e.f. April 1, 2024. (b) Appointment of Shri Anuj Shah (DIN: 10256390) as an INED of the Company a period of 05 years w.e.f. April 1, 2024. (c) Appointment of Shri Akash Modi (DIN: 08698016) as an INED of the Company a period of 05 years w.e.f. April 1, 2024. (d) To consider & approve for giving authorisation to BOD u/s 180(1)(c) of the Companies Act, 2013: (e) To approve & amend material RPT limits with promoter. 2. Approval of Calendar of events for conducting the Postal Ballot seeking approval of the members. The meeting was concluded at 07.45 p.m. (As Per BSE Announcement Dated on 29/04/2024)
29-Mar-2024	29-Mar-2024	Change in Directors	With reference to the above captioned subject, we wish to inform you that the Board of Directors of the Company at their meeting held on Friday, March 29, 2024 at 04.00 p.m. approved the following : 1). The retirement of Shri Sunil C. Modi (DIN : 03103966), upon cessation of his second term as Independent Non-Executive Director w.e.f. March 31, 2024. 2). The retirement Shri Bhushan S. Limaye (DIN : 00804930), upon cessation of his second term as Independent Non-Executive Director w.e.f. March 31, 2024. 3). The retirement Shri Jagadish B. Shetty (DIN : 00731896), upon cessation of his second term as Independent Non-Executive Director w.e.f. March 31, 2024. 4). Reconstitution of the Audit Committee, Nomination and Remuneration Committee and Stakeholders' Relationship Committee of the Board due to cessation of Independent Non-Executive Directors, the composition of the Committees w.e.f April 1 2024 as attached
07-Feb-2024	14-Feb-2024	Quarterly Results	CENTENIAL SURGICAL SUTURE LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2024 inter alia to consider and approve 1. To approve the Standalone Un-Audited Financial Results for the quarter and nine months ended December 31 2023. 2. To approve and appointment of the Independent Non-Executive Directors. 3. Any other business with the permission of chair. With reference to the above captioned subject, we wish to inform you that the Board of Directors of the Company at their meeting held on Tuesday, February 14, 2024 at 06.30 p.m. approved the following: 1. Standalone Un-Audited Financial Results for the quarter and nine months ended December 31, 2023 as per Regulation 33 of SEBI (LODR) Regulations, 2015. 2. Appointment of Shri Akash Modi (DIN: 08698016) as an additional Independent Non-Executive Director of the Company w.e.f. April 1, 2024. 3. Appointment of Shri Anuj Shah (DIN: 10256390) as an additional Independent Non-Executive Director of the Company w.e.f. April 1, 2024. 4. Appointment of Ms. Ridhima Limaye (DIN: 10256393) as an additional Independent Non-Executive Director of the Company w.e.f. April 1, 2024. (As per BSE Announcement Dated on 14/02/2024)
30-Oct-2023	14-Nov-2023	Quarterly Results	CENTENIAL SURGICAL SUTURE LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2023 inter alia to consider and approve 1. To approve Standalone Un-Audited Financial Results for the quarter and half year ended on September 30 2023 pursuant to Regulation 33 of SEBI (LODR) Regulation 2015. 2. To approve the Statement of Assets and Liabilities for the half year ended September 30 2023. 3. Statement of Cash Flow for the half year ended September 30 2023. 4. Any other business with the permission of chair. Please find attachment (As per BSE Announcement Dated on 14/11/2023)
03-Aug-2023	12-Aug-2023	Quarterly Results	CENTENIAL SURGICAL SUTURE LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2023 inter alia to consider and approve 1. To approve Standalone UFR for the quarter ended on June 30 2023 pursuant to Regulation 33 of SEBI (LODR) Regulation 2015. 2. To consider and approve appointment of M/s. HSPN & Associates LLP. Company Secretaries as a Secretarial Auditors of the Company for the Financial Year 2023-2024. 3. To consider and approve appointment of M/s. Utsav Shah & Associates Chartered Accountants as an Internal Auditors of the Company for the Financial Year 2023-2024. 4. To consider and approve re-appointment of Ms. Anuradha Kashikar (DIN : 00804831) as an Executive Director of the Company for further period of 03 (Three) years. 5. To approve the Book-closure dates as per Regulation 42 of the SEBI (LODR) Regulations 2015 for the purpose of 28th Annual General Meeting of the Company. 6. To fix the Date Time and Venue for convening 28th Annual General Meeting of the Members of the Company and approve the Draft Notice for the same. 7. Any other business with the permission of chair. 1). Approval of Standalone UFR for the quarter ended June 30, 2023 2). Limited Review Report 3). Notice of 28th AGM along with Director's & Annual Report 4). Dates of closure of the Share Transfer Books and Register of Members as per Regulation 42 (2) 5). Venue, Day, Date & time of the 28th AGM 6). Fixation of Cut-off date 7) . Re-appointment of Ms. Anuradha Kashikar, (DIN : 00804831) 8). Appointment of Secretarial Auditor 9). Appointment of Internal Auditor 10). Designated Core Team Members of the Company as 'SMP' Intimation of Appointment of Secretarial Auditor Intimation of Re-appointment of Executive Director (As per BSE Announcement Dated on 12/08/2023)
10-May-2023	27-May-2023	Quarterly Results	CENTENIAL SURGICAL SUTURE LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/05/2023 inter alia to consider and approve 1) To approve Standalone Audited Financial Results along with Declaration and Auditors Report for the quarter and year ended on March 31 2023 pursuant to Regulation 33 of SEBI (LODR) Regulations 2015. 2) Any other business with the permission of chair. With reference to the above captioned subject, we wish to inform you that the Board of Directors of the Company at their meeting held on Saturday, the May 27, 2023 approved the following: 1). Approval of Standalone Audited Financial Results for the quarter and year ended March 31, 2023 as per Regulation 33 of SEBI (LODR) Regulations, 2015. 2). Also note that Statutory Auditors of the Company have issued the Auditor's Report for the financial year ended March 31, 2023 with unmodified opinion pursuant to Regulation 33(3)(d) of the SEBI(LODR), Regulations, 2015. 3). Disclosure of Related Party Transaction pursuant to Regulation 23(9) of the SEBI(LODR), Regulations, 2015. The said meeting commenced at 02:15 p.m. and concluded at 03:00 p.m. In pursuance of Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby submit following documents: 1). Standalone Audited Financial Results for the quarter and year ended March 31, 2023. 2). Statutory Auditor's Report for the year ended March 31, 2023. 3). Declaration with respect to audit report with unmodified opinion for the financial year ended on March 31, 2023. (As Per BSE Announcement Dated on 27.05.2023)
06-Feb-2023	14-Feb-2023	Quarterly Results	CENTENIAL SURGICAL SUTURE LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2023 inter alia to consider and approve 1. To approve the Standalone Un-Audited Financial Results for the quarter and nine months ended December 31 2022. 2. Any other business with the permission of chair. With reference to the above captioned subject, we wish to inform you that the Board of Directors of the Company at their meeting held on Tuesday, February 14, 2023 at 02.05 p.m. approved the following: Standalone Un-Audited Financial Results for the quarter and nine months ended December 31, 2022 as per Regulation 33 of SEBI (LODR) Regulations, 2015. The meeting was concluded at 03.35 p.m. (As per BSE Announcement Dated on 14/02/2023)
05-Nov-2022	12-Nov-2022	Quarterly Results	CENTENIAL SURGICAL SUTURE LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/11/2022 inter alia to consider and approve 1. To approve the Standalone Un-Audited Financial Results for the quarter and half year ended September 30 2022. 2. To approve the Statement of Assets and Liabilities for the half year ended September 30 2022. 3. Any other business with the permission of chair. The approved results will be uploaded on BSE Limited website after conclusion of the said meeting. the Board of Directors of the Company at their meeting held on Saturday the November 12, 2022 at 02.55 p.m. approved the following: 1). Standalone Un-Audited Financial Results for the quarter and half year ended September 30, 2022 as per Regulation 33 of SEBI (LODR) Regulations, 2015. 2). Statement of Assets and Liabilities for the half year ended September 30, 2022. 3). Statement of Cash Flow for the half year ended September 30, 2022. 4). Related party transaction for the half year ended September 30, 2022. The meeting was concluded at 04.15 p.m. (As Per BSE Announcement Dated 12.11.2022)
08-Aug-2022	12-Aug-2022	Quarterly Results	Quarterly Results With reference to the above captioned subject, we wish to inform you that the Board of Directors of the Company at their meeting held on Friday, the August 12, 2022 approved the following: ? Standalone Un-Audited Financial Results for the quarter ended June 30, 2022 as per Regulation 33 of SEBI (LODR) Regulations, 2015. The said meeting commenced at 04:30 p.m. and concluded at 04:45 p.m. Kindly take the same on your record. In pursuance of Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby submit following documents: 1). Standalone Un-Audited Financial Results for the quarter ended June 30, 2022. 2). Limited Review Report for the quarter ended June 30, 2022. (As per BSE Announcement Dated on 12/08/2022) In Compliances with Regulation 47 of the SEBI (LODR) Regulations, 2015, please find enclosed herewith copies of the Newspaper Advertisement of the Standalone Un-Audited Financial Results of the Company for quarter ended June 30, 2022 published in all the editions of The Free Press Journal and in Mumbai Edition of Navshakti (Regional Newspaper) on August 13, 2022. (As Per BSE Announcement Dated on 13/08/2022)
23-Jun-2022	27-Jun-2022	AGM	CENTENIAL SURGICAL SUTURE LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 27/06/2022 inter alia to consider and approve 1. Re-appointment and Managerial Remuneration of Shri Vijay Majrekar Managing Director (DIN : 00804808) of the Company. 2. Re-appointment of Shri Devraj T. Poojary Whole Time Director (DIN :02041726) of the Company. 3. Amendment to Notice of the Ensuing 27th Annual General Meeting to be held on August 9 2022 by adding Special Resolution for Re-appointment and Managerial Remuneration of Shri Vijay Majrekar Managing Director (DIN : 00804808). 4. Amendment to Notice of the ensuing 27th Annual General Meeting to be held on August 9 2022 by adding Ordinary Resolution for Re-appointment of Shri Devraj T. Poojary Whole Time Director (DIN : 02041726).
20-May-2022	28-May-2022	Quarterly Results	CENTENIAL SURGICAL SUTURE LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/05/2022 inter alia to consider and approve 1) Standalone Audited Financial Results along with Declaration and Auditors Report for the quarter and year ended on March 31 2022 pursuant to Regulation 33 of SEBI (LODR) Regulations 2015. 2) the Book-closure dates as per Regulation 42 of the SEBI (LODR) Regulations 2015 for the purpose of 27th Annual General Meeting of the Company. 3) To fix the Date Time and Venue for convening 27th Annual General Meeting of the Members of the Company and approve the Draft Notice for the same. 4) Any other business with the permission of chair. The approved results will be uploaded on BSE Limited website after conclusion of the said meeting. Outcome of the Board Meeting held on May 28, 2022 as per attached file In pursuance of Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby submit following documents: 1). Standalone Audited Financial Results for the quarter and year ended March 31, 2022. 2). Auditor's Report for the year ended March 31, 2022. 3). Declaration with respect to audit report with unmodified opinion for the financial year ended on March 31, 2022. (As per BSE Announcement Dated on 28.05.2022) In Compliances with Regulation 47 of the SEBI (LODR) Regulations, 2015, please find enclosed herewith copies of the Newspaper Advertisement of the Standalone Audited Financial Results of the Company for the quarter and year ended March 31, 2022 published in all the editions of The Free Press Journal and in Mumbai Edition of Navshakti (Regional Newspaper) on May 29, 2022. (As Per BSE Announcement Dated on 30/05/2022) This is to inform you that in the meeting of Board of Directors held on Saturday the May 28 2022, the Board had approved the dates of closure of the Share Transfer Books & Register of Members from Thursday the August 4, 2022 to Tuesday the August 9, 2022 (both days inclusive) for the purpose of 27th Annual General Meeting of the Company to be held on Tuesday the August 9, 2022. (As per BSE Announcement Dated on 11/07/2022)

1 2

LOGIN HERE

Centenial Surgical Suture Ltd

Board Meeting